STVN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Stevanato Group SpA (STVN) is not a strong buy at the moment for a beginner investor with a long-term horizon. The stock's recent price decline, lack of significant positive catalysts, and mixed financial performance suggest waiting for a clearer entry point or improved sentiment.
The technical indicators show bearish moving averages (SMA_200 > SMA_20 > SMA_5), suggesting a downward trend. RSI is neutral at 43.941, and MACD is positive but contracting. The stock is trading below the pivot level of 15.779, with key support at 14.463 and resistance at 17.095.
The company reported a 7% revenue increase for fiscal 2025 and optimistic guidance for fiscal 2026, with revenue projected between €1.26 billion and €1.29 billion. High-value solutions contributed significantly to revenue growth.
The stock has experienced a -4.65% drop in regular market trading and an additional -1.63% in pre-market trading. Analysts have lowered price targets, citing near-term engineering segment weakness and moderation in GLP-1 growth. Net income and EPS declined in Q4 2025, and insider/hedge fund trading trends are neutral.
In Q4 2025, revenue increased by 4.81% YoY to €346.5 million, but net income dropped by -1.57% YoY to €47.55 million. EPS decreased by -5.56% YoY to €0.17. Gross margin improved to 31.81%, up 3.45% YoY.
Analysts maintain a generally positive outlook with Buy and Overweight ratings, but price targets have been lowered. KeyBanc and BofA highlight strong demand in biologics and high-value solutions but note headwinds in the engineering segment and moderation in GLP-1 growth.
